Einat Brill Almon
2020
In 2020, Einat Brill Almon earned a total compensation of $884.7K as Senior Vice President, Chief Development Officer at Protalix BioTherapeutics, a 110% increase compared to previous year.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Option Awards | $218,963 |
| Salary | $293,190 |
| Other | $172,513 |
| Total | $884,666 |
Almon received $293.2K in salary, accounting for 33% of the total pay in 2020.
Almon also received $200K in bonus, $219K in option awards and $172.5K in other compensation.
Rankings
In 2020, Einat Brill Almon's compensation ranked 9,113th out of 13,090 executives tracked by ExecPay. In other words, Almon earned more than 30.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,113 out of 13,090 | 30th |
Division Manufacturing | 3,895 out of 5,620 | 31st |
Major group Chemicals And Allied Products | 1,577 out of 2,253 | 30th |
Industry group Drugs | 1,379 out of 1,953 | 29th |
Industry Biological Products, Except Diagnostic Substances | 318 out of 411 | 23rd |
Source: SEC filing on April 29, 2022.
Almon's colleagues
We found two more compensation records of executives who worked with Einat Brill Almon at Protalix BioTherapeutics in 2020.